CORPORATE OVERVIEW

Aria Neurosciences, Inc. (Aria) is an emerging biopharmaceutical company dedicated to developing and commercializing novel disease modifying therapies for Alzheimer’s disease (AD).

 

We have identified a preclinical lead compound from Aria’s chemical library.  Based on the favorable pharmaceutical properties, the Company is confident that it will identify a robust clinical lead candidate molecule within 12 months from financing.

 

The ownership of intellectual property, owned by both Aria Neurosciences and NYU School of Medicine, has been exclusively licensed to Aria for further development.

CONTACT

 

Aria Neurosciences, Inc.

295 Washington Ave, Suite 4N

Hamden, CT 06518

Tel:(203) 815-5782

www.arianeurosciences.com

Alzheimer's Disease

Copyright © 2013 Aria Neurosciences, Inc.

I

I

I